Driving Sustainable Pharmacogenomics (PGx) Sample Volume

Presented By: Becky Winslow, PharmD



Speaker Biography: Best known for her impact on pharmacogenomics testing becoming a standard of care, Dr. Becky Winslow, is a nationally recognized leader in in vitro diagnostics commercialization and clinical adoption strategy. As Founder and President of inGENEious RX, Inc., Dr. Winslow partners with diagnostic companies to accelerate innovative tests from concept to routine clinical practice.

Previously, Dr. Winslow directed medication therapy management programs across retail, hospital, long-term care, and public health sectors for Walmart Inc., Community Health Systems, Inc., and the North Carolina Department of Health and Human Services. Her frustration with the limitations of traditional medication management tools fueled her passion for diagnostics that truly individualize patient care.

For over twelve years, she has guided diagnostic stakeholders in advancing molecular diagnostics and therapeutic strategies to improve patient outcomes. Dr. Winslow frequently presents at leading industry conferences such as the Association for Molecular Pathology and LabRoots educational platforms.

She holds a Bachelor of Science in Biology and a Doctor of Clinical Pharmacy degree from Campbell University and serves as a preceptor for Manchester University School of Pharmacy. Dr. Winslow’s work reflects a commitment to clinical innovation, healthcare transformation, and expanding patient access to high-value diagnostics. Parties interested in learning more about working with Dr. Winslow and inGENEious RX Inc. may email her at [email protected].



Webinar: Driving Sustainable Pharmacogenomics (PGx) Sample Volume



Webinar Abstract: Pharmacogenomics (PGx) testing is a powerful tool in the evolution of personalized medicine. However, for its full potential to be realized, labs must do more than just offer a scientifically sound test—they must figure out how to consistently bring in patient samples at scale. Even with growing clinical interest, many organizations struggle to implement effective and scalable sample acquisition strategies. This presentation takes a focused look at the PGx sample sourcing landscape, offering commercialization teams a clear, step-by-step market segmentation and penetration strategy to turn clinical promise into operational success.

Learning Objectives:

1. Understand and Apply Market Segmentation for PGx Testing - Learn how to systematically identify and prioritize high-value market segments to optimize PGx sample acquisition strategies

2. Design and Execute Market Penetration Strategies - Gain practical knowledge on how to build awareness, enable prescribers, integrate infrastructure, engage payers, and activate utilization pathways to drive sustainable growth in PGx testing adoption

3. Translate Strategy into Action Through Real-World Case Application - Apply a stepwise segmentation and penetration framework in practical healthcare settings, using case study insights to enhance operational success, measure outcomes, and scale PGx programs effectively



Earn PACE Credits: 1. Make sure you’re a registered member of Labroots (https://www.labroots.com/virtual-even...) 2. Watch the webinar on YouTube or on the Labroots Website (https://www.labroots.com/virtual-even...) 3. Click Here to get your PACE credits (Expiration date –11/12/2026): (https://www.labroots.com/virtual-even...) This link will be located in the CMS in the webinar CE tab – please enable third party PACE link



Labroots on Social:
Facebook:   / labrootsinc  
Twitter:   / labroots  
LinkedIn:   / labroots  
Instagram:   / labrootsinc  
Pinterest:   / labroots  
SnapChat: labroots_inc